SCHEMBL7302246

SCHEMBL7302246

O=C(C[C@@H]1CCc2ccccc2C1)C1C(=S)CN[C@@H]1C(=O)N1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PREP P48147 19/20 0.54
UGCG Q16739 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7296356 1.00 PREP (0.54) PREPUGCG
SCHEMBL7294240 1.00 PREP (0.54) PREPUGCG
SCHEMBL7292981 0.93 PREP (0.48) PREP
SCHEMBL7295937 0.88 PREP (0.57) PREP
SCHEMBL7297854 0.88 PREP (0.57) PREP
SCHEMBL7301347 0.88 PREP (0.57) PREP
SCHEMBL9048719 0.86 PREP (0.46) PREP
SCHEMBL8146773 0.86 PREP (0.46) PREP
SCHEMBL7295069 0.86 CYP26A1 (0.42) PREPUGCG
SCHEMBL8161220 0.85 PREP (0.46) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6017929-A Cholinesterase activator ZERIA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed
EP-0754454-A1 CHOLINESTERASE ACTIVATOR ZERIA PHARMACEUTICAL CO., LTD. (JP) 1997-01-22 EP disclosed
EP-0372484-B1 Condensed benzene derivative ZERIA PHARM CO LTD (JP) 1994-10-26 EP disclosed
US-5028604-A Cognition Activators ZERIA PHARMACEUTICAL CO., LTD. (JP) 1991-07-02 US disclosed
EP-0372484-A2 Condensed benzene derivative ZERIA PHARMACEUTICAL CO., LTD. (JP) 1990-06-13 EP disclosed